CONNETTIVINA * CREAM 15G 2MG / G

CONNETTIVINA * CREAM 15G 2MG / G

Therapeutic indications

Treatment of abrasions, bruises, superficial wounds, burns, minor burns and breast fissures. Treatment of localized skin irritations caused by physical agents such as sun, cold, wind, diaper rash, irritation and dehydration resulting from radiotherapy treatments.

Dosage and method of use

CONNETTIVINA 2 mg / g Cream, CONNETTIVINA 2 mg / g Gel: 2-3 applications per day, evenly covering the entire affected area.

Contraindications

Hypersensitivity to the active substance and other chemically closely related substances or to any of the excipients listed in section 6.1.

Side effects

Following the application of CONNETTIVINA, local reactions, including allergic ones, were recorded. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http://www.agenziafarmaco.gov.it/it/responsabili.

Special warnings

The use of the product, especially if prolonged, can give rise to sensitization phenomena. If this happens, treatment must be discontinued and appropriate therapy instituted.

Pregnancy and breastfeeding

The drug can be used during pregnancy and breastfeeding.

Expiration and retention

Cream: do not store above 30 ° C. Gel: Do not store above 25 ° C.

Interactions with other drugs

The association of hyaluronic acid with antibiotics and other local treatments has never given rise to interaction phenomena. Do not use simultaneously with disinfectants containing quaternary ammonium salts as hyaluronic acid can precipitate in their presence.

Overdose

There are no known cases of CONNETTIVINA overdose.

Active principles

CONNETTIVINA 2mg / g Cream: 1 g of cream contains 2 mg of Hyaluronic acid sodium salt. Excipients with known effects: methyl p-hydroxybenzoate and propyl p-hydroxybenzoate. CONNETTIVINA 2 mg / g Gel: 1 g of gel contains 2 mg of Hyaluronic acid sodium salt. Excipients with known effects: methyl p-hydroxybenzoate and propyl p-hydroxybenzoate. For the full list of excipients, see section 6.1

Excipients

CONNETTIVINA 2 mg / g Polyethylene glycol cream 400 monostearate - decyl ester of oleic acid - emulsifying wax - glycerol - sorbitol solution 70% - methyl p-hydroxybenzoate - propyl p-hydroxybenzoate - aroma (Dalin PH) - purified water CONNETTIVINA 2 mg / g Non crystallizable 70% sorbitol gel - methyl p-hydroxybenzoate - propyl p-hydroxybenzoate - Carbomer - sodium hydroxide - purified water